Followers | 434 |
Posts | 57599 |
Boards Moderated | 5 |
Alias Born | 01/09/2007 |
Tuesday, September 07, 2010 5:34:22 PM
BY Midnight Trader
— 5:29 PM ET 09/07/2010
05:29 PM Eastern Daylight Time, 09/07/2010 (MidnightTrader) --
Bristol-Myers Squibb Company (BMY) and ZymoGenetics (ZGEN) have signed a definitive agreement providing for the acquisition of ZymoGenetics (ZGEN) by Bristol-Myers Squibb (BMY) for $9.75 per share in cash. The transaction, with an aggregate purchase price of approximately $885 million, or approximately $735 million net of cash acquired, has been unanimously approved by the boards of directors of both companies. The board of directors of ZymoGenetics (ZGEN) intends to recommend that ZymoGenetics' (ZGEN) shareholders tender their shares in the tender offer. In addition, shareholders holding approximately 37% of the outstanding shares of ZymoGenetics' (ZGEN) common stock have entered into agreements with Bristol-Myers Squibb (BMY) to support the transaction and to tender their shares in the offer. BMY says the acquisition builds on long-standing commitment to virology; gains full rights to promising Phase II hepatitis C biologic, pegylated-interferon lambda; obtains FDA-approved specialty surgical biologic, RECOTHROM; attains early clinical and pre-clinical programs in oncology and immunoscience. ZGEN is halted; BMY is down 0.3%. Price: 5.30, Change: 0, Percent Change: 0
http://www.midnighttrader.com
10/5/07 -- there are no coincidences here ...
oh and like many other longs .. not selling at this level --
Recent ZGEN News
- BMO annonce les évaluations finales et déclare les distributions finales sur les parts de cinq fonds négociés en bourse BMO qui ont été dissous • PR Newswire (Canada) • 12/16/2023 01:38:00 AM
- BMO Announces Final Valuations and Declares Final Distributions on Units of Five Terminated BMO Exchange Traded Funds • PR Newswire (Canada) • 12/16/2023 01:26:00 AM
- BMO annonce des distributions annuelles réinvesties estimatives à l'égard des fonds négociés en bourse BMO et de la série de FNB de BMO • PR Newswire (Canada) • 11/28/2023 01:44:00 PM
- BMO Announces Estimated Annual Reinvested Distributions for BMO Exchange Traded Funds and ETF Series • PR Newswire (Canada) • 11/28/2023 01:37:00 PM
- BMO annonce une proposition de dissolution de certains FNB BMO • PR Newswire (Canada) • 09/29/2023 09:00:00 PM
- BMO Announces Proposed Termination of Certain BMO ETFs • PR Newswire (Canada) • 09/29/2023 09:00:00 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM